Dr. Kahl on Remaining Challenges in Indolent Non-Hodgkin Lymphoma
0 Views
administrator
07/09/23
Brad S. Kahl, MD, a medical oncologist at Siteman Cancer Center and a professor of medicine in the Division of Oncology at Washington University School of Medicine in St. Louis, discusses remaining challenges in the indolent non-Hodgkin lymphoma (iNHL) treatment landscape.
Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive
-
Category
Show more
Facebook Comments
No comments found